You are here

LibiGel

Biosante: Key Catalysts Should Renew Investor Interest

Seeking Alpha

Fri, 10/1/10 - 10:16 am

female sexual dysfunction

Six Trades on FDA, Clinical Trial Binary Events

Seeking Alpha

Tue, 07/13/10 - 09:14 pm

Protalix BioTherapeutics

cancer vaccines

Biosante Pharmaceuticals continues study of LibiGel drug for female sexual desire disorder

Yahoo/AP

Mon, 06/21/10 - 12:09 pm

female sexual dysfunction

BioSante says panel recommends drug trial to continue

Reuters

Mon, 02/22/10 - 09:32 am

Pages